Literature DB >> 3297009

Current strategies for the management of aneurysmal subarachnoid hemorrhage.

R A Solomon, M E Fink.   

Abstract

Subarachnoid hemorrhage (SAH) from a ruptured intracranial aneurysm represents a major health issue. Although most people who experience an aneurysmal SAH survive to be admitted to a hospital, less than one third of these patients ever return to their premorbid status. Clearly, morbidity of this magnitude demands reevaluation of the clinical approach to this problem. This article reviews the natural history of aneurysmal SAH, and examines the current therapeutic strategies that have been suggested to improve the outcome. Careful evaluation of the existing data suggests that early aneurysm surgery and aggressive postoperative volume expansion therapy constitute the best presently available approach to patients with ruptured intracranial aneurysms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297009     DOI: 10.1001/archneur.1987.00520190073018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Differential diagnosis of spontaneous and traumatic intracranial haemorrhage.

Authors:  P Berlit; J Rakicky; K Tornow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

2.  Neuropsychological outcome of patients operated upon for an intracranial aneurysm: analysis of general prognostic factors and of the effects of the location of the aneurysm.

Authors:  A Desantis; M Laiacona; R Barbarotto; A Basso; R Villani; D Spagnoli; E Capitani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-10       Impact factor: 10.154

3.  Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.

Authors:  F Porchet; R Chioléro; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Guglielmi detachable coil treatment of ruptured saccular cerebral aneurysms: retrospective review of a 10-year single-center experience.

Authors:  Jonathan A Friedman; Douglas A Nichols; Fredric B Meyer; Mark A Pichelmann; Jon I McIver; L Gerard Toussaint; Patsy L Axley; Robert D Brown
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.